These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22879796)

  • 1. Rosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia.
    Abbas A; Milles J; Ramachandran S
    Clin Med Insights Endocrinol Diabetes; 2012; 5():13-30. PubMed ID: 22879796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
    J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.
    Kones R
    Drug Des Devel Ther; 2010 Dec; 4():383-413. PubMed ID: 21267417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study.
    Simsek S; Schalkwijk CG; Wolffenbuttel BH
    Diabet Med; 2012 May; 29(5):628-31. PubMed ID: 22151023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the efficacy of rosuvastatin in patients with type 2 diabetes.
    Tuomilehto J; Leiter LA; Kallend D
    Int J Clin Pract Suppl; 2004 Oct; (143):30-40. PubMed ID: 16035394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Statins Counteract the Effect of Antidiabetic Drugs? Results of the SCEAD Study.
    Tarim BA; Fici F; Tengiz I; Avunduk S; Ozcan Y; Faikoglu G; Ari E; Robles NR; Grassi G
    Yonsei Med J; 2023 Mar; 64(3):175-180. PubMed ID: 36825343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.
    Mora S; Glynn RJ; Hsia J; MacFadyen JG; Genest J; Ridker PM
    Circulation; 2010 Mar; 121(9):1069-77. PubMed ID: 20176986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study.
    Liu WT; Lin C; Tsai MC; Cheng CC; Chen SJ; Liou JT; Lin WS; Cheng SM; Lin CS; Tsao TP
    Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33202854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of incident diabetes among patients treated with statins: population based study.
    Carter AA; Gomes T; Camacho X; Juurlink DN; Shah BR; Mamdani MM
    BMJ; 2013 May; 346():f2610. PubMed ID: 23704171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins.
    Choi JY; Choi CU; Choi BG; Park Y; Kang DO; Jang WY; Kim W; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Jeong MH; Chae SC; Seong IW; Yoon CH; Cha KS; Oh SK;
    BMC Pharmacol Toxicol; 2021 Feb; 22(1):11. PubMed ID: 33541430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy.
    Lorenzi M; Ambegaonkar B; Baxter CA; Jansen J; Zoratti MJ; Davies G
    Clin Res Cardiol; 2019 May; 108(5):487-509. PubMed ID: 30302558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
    Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA
    Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes.
    Han E; Kim G; Lee JY; Lee YH; Kim BS; Lee BW; Cha BS; Kang ES
    Endocrinol Metab (Seoul); 2017 Jun; 32(2):274-280. PubMed ID: 28685516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.
    Hodkinson A; Tsimpida D; Kontopantelis E; Rutter MK; Mamas MA; Panagioti M
    BMJ; 2022 Mar; 376():e067731. PubMed ID: 35331984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
    Kostapanos MS; Milionis HJ; Elisaf MS
    Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases.
    Seo WW; Seo SI; Kim Y; Yoo JJ; Shin WG; Kim J; You SC; Park RW; Park YM; Kim KJ; Rhee SY; Park M; Jin ES; Kim SE
    Cardiovasc Diabetol; 2022 May; 21(1):82. PubMed ID: 35606846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome.
    Bener A; Dogan M; Barakat L; Al-Hamaq AO
    J Prim Care Community Health; 2014 Jul; 5(3):180-7. PubMed ID: 24522932
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.